FDA approves Lupin's generic diabetes drug

07/22/2013 | Business Standard (India) · RTT News

The FDA has granted Lupin Pharmaceuticals approval for its metformin hydrochloride extended release tablets in 500 mg and 1000 mg strengths to boost glucose control in patients with type 2 diabetes. The drug is a generic version of Santarus' Glumetza HCl ER Tablets.

View Full Article in:

Business Standard (India) · RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA